Skip Navigation


Hum. Reprod. Advance Access originally published online on June 3, 2006
Human Reproduction 2006 21(9):2329-2334; doi:10.1093/humrep/del174
This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/9/2329    most recent
del174v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Portnoï, M.F.
Right arrow Articles by Christin-Maitre, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Portnoï, M.F.
Right arrow Articles by Christin-Maitre, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Molecular cytogenetic studies of Xq critical regions in premature ovarian failure patients

M.F. Portnoï1, A. Aboura2, G. Tachdjian2, P. Bouchard3, D. Dewailly4, N. Bourcigaux3, R. Frydman5, Anne-Céline Reyss4, Sophie Brisset2 and S. Christin-Maitre3,6

1 Laboratoire de cytogénétique, Hôpital Saint-Antoine, Paris 2 Service de biologie et génétique de la reproduction, INSERM U782, Hôpital Antoine Béclère, Clamart 3 UPRES 1533, Université Pierre et Marie Curie, Service d’Endocrinologie de la Reproduction, Assistance-Publique Hôpitaux de Paris, Hôpital Saint-Antoine, Paris 4 Service d’Endocrinologie de la reproduction Hôpital Jeanne de Flandres, Lille and 5 Service de gynécologie-obstétrique, INSERM U782, Hôpital Antoine Béclère, Clamart, France

6 To whom correspondence should be addressed at: UPRES 1533, Université Pierre et Marie Curie, Service d’Endocrinologie de la Reproduction, Assistance-Publique Hôpitaux de Paris, Hôpital Saint-Antoine, 75012 Paris, France. E-mail: sophie.christin-maitre{at}sat.aphp.fr


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
BACKGROUND: Premature ovarian failure (POF) is defined as amenorrhoea for more than 6 months, occurring before the age of 40, with an FSH serum level higher than 40 mIU/ml. Cytogenetically visible rearrangements of the X chromosome are associated with POF. Our hypothesis was that cryptic Xq chromosomal rearrangements could be an important etiological contributor of POF. METHODS: Ninety POF women were recruited and compared to 20 control women. Peripheral blood samples were collected and metaphase chromosomes were prepared using standard cytogenetic methods. To detect Xq chromosomal micro-rearrangements, fluorescence in situ hybridization (FISH) analysis was performed using a selection of 30 bacterial artificial chromosome (BAC) and P1 artificial chromosome clones, spanning Xq13–q27. We further localized the translocation breakpoints by FISH with additional BAC clones. RESULTS: Chromosomal abnormalities were identified in 8.8% of our 90 patients [one triple X, three large Xq deletions 46,X,del(X)(q22.3), 46,X,del(X)(q21.2) and 46,X,del(X)(q21.32), two balanced X;autosome translocations 46,X,t(X;1) (q21.1;q32) and 46,X,t(X;9)(q21.31;q21.2) and two Robertsonian translocations 45,XX,der(15;22)(q10;q10) and 45,XX,der(14;21)(q10;q10)]. The two Xq translocation breakpoints were among a cluster of repetitive elements without any known genes. FISH analysis did not reveal any Xq chromosomal micro-rearrangement. CONCLUSIONS: Karyotyping is definitely helpful in the evaluation of POF patients. No submicroscopic chromosomal rearrangements affecting Xq region were identified. Further analysis using DNA microarrays should help delineate Xq regions involved in POF.

Key words: deletion/molecular cytogenetic/premature ovarian failure/translocation/X chromosome


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Premature ovarian failure (POF; OMIM 311360 [OMIM] ) is defined as amenorrhoea for more than 6 months in the presence of raised gonadotrophins, FSH serum level higher than 40 mIU/ml, occurring before the age of 40 (Coulam et al., 1986Go; Vegetti et al., 2000Go). Ovarian failure can be induced by viral or autoimmune oophoritis, environmental toxins, pelvic surgery, radiations or chemotherapy. Mutations in several genes such as ATM, AIRE, FSH receptor, GALT1, BMP15, FOXL2 and inhibin {alpha} genes and FMR1 premutation have been related to POF (see review in Goswami and Conway, 2005Go). Furthermore, abnormalities of the X chromosome have been reported in POF patients. Cytogenetically visible rearrangements of the X chromosome are associated with POF. Many of those rearrangements occur in specific Xq regions. Two main critical regions have been located on the long arm of the X chromosome, at Xq13–q21 (Powell et al., 1994Go) and at Xq26–q27 (Krauss et al., 1987Go). However, conventional karyotyping has a resolution of 5–10 Mb and does not detect all chromosomal alterations. In clinical cytogenetics, several new methods such as fluorescence in situ hybridization (FISH) and other molecular techniques have been developed, to detect submicroscopic rearrangements, not visible by routine chromosome analysis. This strategy identified previously unrecognized chromosomal causes of mental retardation (Knight et al., 1999Go). Therefore, our hypothesis was that cryptic chromosomal rearrangements affecting Xq region could be an important etiological contributor of POF.

The purpose of this study was to uncover submicroscopic chromosomal anomalies by testing loci potentially involved in the pathogenesis of POF. In this study, 90 patients with POF and 20 control women were analysed, using FISH with bacterial artificial chromosome (BAC) and P1 artificial chromosome (PAC) clones, spanning areas of Xq chromosome known to be rearranged in POF patients.


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Patients
Women were recruited from three clinical centres: Hôpital Saint-Antoine, Paris, Hôpital Jeanne de Flandres, Lille, and Hôpital Antoine Béclère, Clamart. Inclusion criteria were primary amenorrhoea or secondary amenorrhoea for more than 6 months, occurring before the age of 40, with an FSH serum level higher than 40 mIU/ml. The study was approved by the institutional review board of Saint-Antoine hospital, and all participants gave their written informed consent.

Ninety patients participated in the study. Women with clinical stigmata of Turner’s syndrome were excluded from the study, as well as two patients with blepharophimosis syndrome. Fourteen patients presented with primary amenorrhoea (15.6%). Among the remaining patients, the mean age at first menses was 13.02 years, ranging from 10 to 18 years. The mean age at menopause was 29.4 ± 6.5 years (mean ± SD). A family history of POF was found in 18 patients (20%). A personal history of autoimmunity was identified in seven patients (7.78%).

Controls
Women with regular menses (28–32 days) having at least one child and no personal history of infertility or autoimmune disease were selected as controls. Twenty control women were recruited and gave their informed consent.

Conventional cytogenetic analysis
Peripheral blood samples were collected and metaphase chromosomes were prepared using standard cytogenetic methods. Twenty metaphase spreads, GTG or RHG banded, were routinely analysed from each patient. Karyotypes of peripheral lymphocytes in patients and controls were analysed. When possible, samples from the parents of the patients carrying anomalies were also cytogenetically analysed.

FISH
FISH analysis was performed and processed, by standard procedures, using DNA fluorescent probes for the DXZ1-alpha satellite probe (Vysis, Inc., Downers Grove, IL, USA) for detecting X chromosome mosaicism. Fifty metaphases and 200 interphase cells were analysed from each patient.

To exclude a potential complex rearrangement in Xq deletions and X;autosome translocations, chromosome painting using whole X, 1 and 9 chromosome probes (Vysis) was performed. Subtelomeric Xq chromosome FISH analysis was performed to characterize Xq deletions.

To detect Xq chromosomal micro-rearrangements, FISH analysis was performed using a selection of 30 BAC and PAC clones (from the Wellcome Trust Sanger Institute, UK, and from M. Rocchi, University of Bari, Italy), spanning Xq13–q27. Clones across Xq13–q21 and Xq26–q27 were spaced at ~1 Mb interval (Figure 1). To define our translocation breakpoints, 33 additional BAC and PAC clones were used in our FISH analysis.


Figure 1
View larger version (28K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Figure 1. Bacterial artificial chromosome and P1 artificial chromosome clones spanning the Xq chromosome.

 
Clones were plated and propagated, and glycerol stocks were prepared. Isolation and purification of DNA were performed using the Qiagen plasmid Maxi Kit (Qiagen SA; Courtaboeuf, France), according to the manufacturer’s instructions. FISH probes were created using purified BAC and PAC DNA by using a nick translation kit to incorporate Spectrum Green or Spectrum Red dUTP, as per manufacturer’s instruction (Vysis). The labelled DNA probes were applied to interphase and metaphase cells obtained from the patients and controls. For each probe, 10 metaphases were analysed.


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Cytogenetic investigations
A total of 90 cases of POF-affected women and 20 female controls were analysed.

Eight chromosome rearrangements were identified in POF patients (8.8%) by conventional cytogenetic analysis of GTG- or RHG-banded chromosomes from peripheral lymphocytes. One patient had triple X, five patients had structural anomalies involving the long arm of X chromosome and two patients were carrying a Robertsonian translocation, with 45,XX,der (15;22)(q10;q10) and 45,XX,der(14;21)(q10;q10) karyotypes. The structural abnormalities of the Xq chromosome showed three large Xq deletions 46,X,del(X)(q22.3), 46,X,del(X)(q21.2) and 46,X,del(X)(q21.3) and two (X;autosome) balanced translocations 46,X,t(X;1)(q21.1;q32) and 46,X,t(X;9)(q21.3;q21.2) (Figure 2). 45,X/46,XX and 46,XX/47,XXX mosaicisms or other complex mosaicisms involving X chromosome were not observed in any patients or controls. The Xq21.2 and Xq22.3 deletions occurred de novo. The mode of inheritance was not identified for the other abnormalities, because of non-availability of parental karyotypes.


Figure 2
View larger version (17K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Figure 2. Xq chromosome mapping of breakpoints in patients with X chromosome deletion (n = 3) and in patients with a (X;autosome) translocation (n = 2).

 
FISH analysis
FISH analysis with the X-specific centromeric probe (DXZ1) showed two positive signals in the total counted 50 metaphases and in at least 97% of the 200 interphase nuclei analysed (Figure 3A). A single X-chromosome signal was found in <3% of the total counted cells, which was not significantly greater than that in the controls. This indicates the absence of mosaic constitution in all patients and controls. All cases with chromosome rearrangements were non-mosaic.


Figure 3
View larger version (48K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Figure 3. (A) Dual colour (red and green) fluorescence in situ hybridization (FISH) showing two normal X chromosomes. (B) Dual colour FISH showing one normal X chromosome and one deleted X chromosome (arrow). (C) Whole X chromosome painting showing one normal X chromosome (green) and one deleted X chromosome (arrow). (D) Whole X chromosome (green) and chromosome 1 (red) painting showing the (X;1) translocation.

 
The triple X was present in all 50 metaphases and 200 interphase nuclei analysed. Additional FISH study with DXZ1 probe performed on buccal mucosal cells of this patient confirmed the absence of mosaic.

In the three cases of Xq deletions, FISH with BAC clones spanning the breakpoint regions was used (Figure 3B). FISH using the whole X chromosome painting probe revealed complete hybridization on normal and deleted X chromosomes, thus excluding any translocation (Figure 3C). After FISH with BAC clones spanning the breakpoint regions, the deletion breakpoints were located respectively at q21.2, q21.31 and q22.33. FISH analysis using Xqter probe confirmed terminal Xq deletions in all cases.

FISH with the whole chromosome-specific paints of X, 1 and 9 confirmed the balanced (X;autosome) translocations in t(X,1) and t(X,9) patients (Figure 3D). The Xq breakpoint of the (X;1) translocation was mapped in Xq21.1, between RP11-346E8 and RP1-63M23 BACs and between 80.40 and 80.95 Mb of the X chromosome. The two clones defined an interval of 550 kb. This interval was not further defined, as analysis of this region revealed that it does not contain any known gene (http://www.ensembl.org/index.html). The Xq breakpoint of the (X;9) translocation was more distal, as it mapped in Xq21.31. The breakpoint was in the overlapping BAC RP13-428K23, between 89.93 and 90.02 Mb of the X chromosome, in a breakpoint interval of 190 kb. Each Xq breakpoint falls among a cluster of repetitive elements (http://www.ensembl.org/index.html). Thus, the breakpoints fall in DNA segments that are essentially untranscribed, ~10 Mb apart in Xq21.

FISH analysis was performed in each patient using Xq chromosome locus-specific probes, 30 large insert clones (BAC) spanning Xq13–q27, spaced at ~1 Mb intervals across Xq13–q21 and Xq26–q27. No Xq chromosomal micro-rearrangement was detected as normal signal patterns on both X chromosomes were present on Xq with the BAC clones used. Therefore, no microdeletion and no microduplication of Xq chromosome were identified within this cohort of 90 POF patients.


    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
An association between POF and abnormalities of the X chromosome has been extensively reported in the literature (Goswami and Conway, 2005Go). A Dutch study has recently suggested that the involvement of the X chromosome may not be limited to POF but may influence the broader spectrum of menopausal age (van Asselt et al., 2004Go). In POF patients, deletions of the X chromosome have suggested two main critical regions located in Xq13.3–q22 (Powell et al., 1994Go) and Xq26–q28 (Tharapel et al., 1993Go). Few deletions in distal Xq have been reported. Marozzi et al. (2000)Go described six POF patients with rearranged Xq chromosomes and confirmed that the second region extends from Xq26.2 to Xq28. Rossetti et al. (2004)Go have reported an interstitial and distal deletion of the X chromosome in two affected women and their fertile mother. Recently, Eggermann et al. (2005)Go have narrowed the distal region after a case report of a woman with a small deletion spanning from Xq27.2/Xq27.3 to Xqter in a familial case of POF with secondary amenorrhoea. Balanced X;autosome translocations have been reported in more than 100 POF women (Schlessinger et al., 2002Go). The breakpoints are distributed over the whole X chromosome. Nevertheless, they cluster in the region located between Xq13 and Xq26. Rizzolio et al. (in press)Go have mapped 25 new cases of chromosomal rearrangements in Xq. Most balanced X;autosome translocations and deletions fall in a region from Xq13 to Xq27. Although other regions on the X chromosome have been linked to POF, such as Xp and proximal Xq28 (Rossetti et al., 2004Go), we focused our study on Xq13–q23 and Xq26–q27 and decided to look for chromosomal rearrangements in those regions, in a large cohort of POF patients. We excluded women with syndromic POF, such as Turner’s and blepharophimosis syndrome, to focus our study on idiopathic POF.

In our population of 90 POF patients, we found chromosomal abnormalities in 8.8% of patients (a single case of triple X, three cases of Xq deletions, two cases of X;autosome translocations and two cases of Robertsonian translocations).

We identified three patients with large terminal Xq deletions, involving Xq21–qter. Our study, however, did not exclude a complex rearrangement such as cryptic X;autosome unbalanced translocation, because we did not use a panel of all human subtelomeric probes.

Previous sporadic or very few instances of familial POF associated with different-sized Xq interstitial and terminal deletions have been reported (Krauss et al., 1987Go; Maraschio et al., 1996Go; Rizzolio et al., in press). The main region is located at Xq13–q25 (Simpson and Rajkovic, 1999Go). The molecular mechanism based on the POF phenotype could be due to haploinsufficiency of genes located within the deleted region and normally escaping the X inactivation. Maraschio et al. (1996)Go reported that the same deletion can have different clinical consequences on menses and fertility. However, the majority of patients with Xq deletions have oligomenorrhoea, followed by secondary amenorrhoea or premature menopause, irrespective of the size of the deletion (Therman et al., 1990Go). Our three patients presented with secondary amenorrhoea, at the age of 19, 32 and 33, respectively. All of them had primary infertility.

Breakpoints of our two balanced translocations 46,X,t(X;1) (q21.1;q32) and 46,X,t(X;9)(q21.31;q21.2) fall in the Xq proximal region, previously identified as POF2 (Powell et al., 1994Go). Bione et al. (1998)Go have previously demonstrated that a balanced (X;12)(q21;p13) translocation in a POF family interrupts a human homologue of the Drosophila melanogaster gene diaphanous (DIAPH2). However, no other DIAPH2 mutations have been identified in a cohort of POF women (Bione et al., 2004Go). Breakpoints associated with POF fall within genes having no obvious relationship with ovarian function (Prueitt et al., 2000Go, 2002Go; Bione et al., 2004Go). Other translocations previously described fall in poorly transcribed regions (Mumm et al., 2001Go; Schlessinger et al., 2002Go; Rizzolio et al., in press). Fine mapping of our two Xq breakpoints identified that they fall in regions of repetitive elements in Xq21, ~10 Mb apart in regions without known genes. In theory, gonadal dysfunction related to chromosomal abnormalities can occur for several reasons. The first one is linked to critical gene expression being disrupted by the rearrangement (Sala et al., 1997Go). The second one is related to temporally inappropriate gene expression following incomplete pairing of X chromosomes at pachytene, leading to meiotic arrest (Sala et al., 1997Go; Schlessinger et al., 2002Go). A third potential explanation is a position effect. Rizzolio et al. (in press)Go suggested that POF should be ascribed to a position effect of the breakpoints on flanking X-linked genes or on genes flanking the autosomal breakpoints. Our findings related to breakpoints falling within a region of repetitive elements in Xq are in favour of alterations in chromosome meiotic pairing or position effect.

Clinically, the 46,X,t(X;1)(q21.1;q32) patient presented with primary amenorrhoea. The 46,X,t(X;9)(q21.31;q21.2) patient had secondary amenorrhoea at the age of 25, occurring later than previously described. Indeed, translocations involving this Xq chromosomal region are known to cause amenorrhoea between the age of 16 and 21 years (Powell et al., 1994Go). Therefore, our data emphasize the importance of the Xq proximal region in POF.

Concerning the Robertsonian translocations, very few cases associated with POF have been reported in the literature (Orczyk et al., 1989Go; Kawano et al., 1998Go). Our patients presented a translocation between chromosome 15 and chromosome 22 [45,XX,der(15;22)(q10;q10)] and between chromosome 14 and 21 [5,XX,der(14;21)(q10;q10)]. Robertsonian translocations are the most frequent translocations reported in humans (Scriven et al., 2001Go). Thus, the presence of those translocations could be coincidental. Nevertheless, Robertsonian translocations are associated with spermatogenesis failure in men (Van Assche et al., 1996Go). The correlation between those Robertsonian translocations and the ovarian phenotype in our patients can only be suggested.

One of our patients presented with triple X. The triple X incidence is estimated to be 1/1000 live born females. Most of them have normal physical appearance and puberty. Several sporadic cases of triple X women associated with POF have been reported (Villanueva and Rebar, 1983Go; Itu et al., 1990Go; Holland, 2001Go). In the study by Goswami et al. (2003)Go, the prevalence of triple X among 52 POF women reached 3.8%. In our population, the prevalence is lower, reaching 1.1%. Our patient presented her first menses at the age of 13 and secondary amenorrhoea occurred at the age of 21. Her height was 165 cm with a weight of 80 kg. She had no stigmata of autoimmunity, although hypothyroidism has been previously reported in POF triple X women (Goswami et al., 2003Go).

In our cohort, we did not identify any X/XX, XX/XXX mosaicism or any mosaicism involving X chromosome. Previous studies including unexplained secondary hypergonadotrophic hypogonadism have reported low levels of X/XX mosaicisms (Wu et al., 1993Go; Devi et al., 1998Go). In 15 patients with a normal 46,XX karyotype, a FISH study revealed a statistically significant increase in the frequency of cells showing a single X-chromosome signal compared to normal women (mean 5.5, P < 0.001) (Devi et al., 1998Go). However, we studied a large amount of cells, 70 metaphases and 200 interphase nuclei excluding low-grade X/XX mosaicism.

In our selected POF population, our extensive molecular cytogenetic study did not reveal any cryptic chromosomal rearrangements affecting critical Xq regions. Although those data may be surprising, as microdeletions are generally rather common, our results suggest that cryptic rearrangements in the Xq critical region are unlikely to be a common cause of POF. We used BACs spanning Xq13–27, spaced at ~1 Mb intervals across Xq13–q21 and Xq26–q27. This resolution is similar to most of the reliable CGH array assays currently available. Furthermore, as we focussed on critical Xq regions involved in POF patients, the number of 30 clones could be considered as sufficiently high to detect most micro-rearrangements in those two regions. Nevertheless, we cannot exclude the possibility that resolution of our study was not high enough to detect potential Xq interstitial chromosomal abnormalities. Moreover, lack of small deletions could also be explained by others factors such as chromatin effects or monosomy for ovary-specific autosomal genes for the POF phenotype (Rizzolio et al., in press).

In conclusion, we identified 8.8% of X chromosome abnormalities in a large population of POF patients, excluding patients with clinical stigmata of Turner’s syndrome, implying that karyotyping is helpful in the evaluation of POF patients. The Xq breakpoints of two balanced X;autosome translocations have no putative or detected gene content. Moreover, in our cohort, no cryptic chromosomal rearrangements affecting Xq region were identified using FISH studies with a 1 Mb resolution. Further studies using DNA microarrays allowing a high chromosomal resolution analysis will help delineate the Xq critical region in POF patients.


    Acknowledgements
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
We thank Mrs Lina Finkel and Ghislaine Rousseau for technical assistance, Drs C. Djakoure, B. Emperauger, J. Mandelbaum and N. Ronci-Chaix for referring patients, Dr O. Lascols for extracting DNA, and Dr Tabassome Simon from URCEST, Saint-Antoine. This study was supported by Direction de la Recherche Clinique, Assistance Publique Hôpitaux de Paris (PHRC AOR016).


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Bione S, Rizzolio F, Sala C, Ricotti R, Goegan M, Manzini MC, Battaglia R, Marozzi A, Vegetti W, Dalpra L, et al. (2004) Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B. Hum Reprod 19:2759–2766.[Abstract/Free Full Text]

Bione S, Sala C, Manzini M, Arrigo G, Zuffardi O, Banfi S, Borsani G, Jonveaux P, Philippe C, Zuccotti M, et al. (1998) A human homologue of the Drosophila melanogaster gene is disrupted in a patient with premature ovarian failure: evidence for conserved function in oogenesis and implications for human sterility. Am J Hum Genet 62:533–541.[CrossRef][Web of Science][Medline]

Coulam C, Adamson SC, Annegers JF. (1986) Incidence of premature ovarian failure. Obstet Gynecol 67:604–606.[Web of Science][Medline]

Devi AS, Metzger DA, Luciano AA, Benn PA. (1998) 45 X,46XX mosaicism in patients with idiopathic premature ovarian failure. Fertil Steril 70:89–93.[CrossRef][Web of Science][Medline]

Eggermann T, Meschede D, Schuler H, Palm S, Glaser D, Horsthemke B, Eggermann K, Haverkamp F, Zerres K. (2005) Premature ovarian failure associated with a small terminal Xq deletion: narrowing the POF1 region down to Xq27.2/Xq27.3-qter. Clin Genet 67:434–437.[CrossRef][Web of Science][Medline]

Goswami D and Conway GS. (2005) Premature ovarian failure. Hum Reprod Update 11:391–409.[Abstract/Free Full Text]

Goswami R, Goswami D, Kabra M, Gupta N, Dubey S, Dadhwal V. (2003) Prevalence of the triple X syndrome in phenotypically normal women with premature ovarian failure and its association with autoimmune thyroid disorders. Fertil Steril 80:1052–1054.[CrossRef][Web of Science][Medline]

Holland CM. (2001) 47,XXX in an adolescent with premature ovarian failure and autoimmune disease. J Pediatr Adolesc Gynecol 14:77–80.[CrossRef][Medline]

Itu M, Neelam T, Ammini AC, Kucheria K. (1990) Primary amenorrhea in a triple X female. Aust N Z J Obstet Gynaecol 30:386–388.[Web of Science][Medline]

Kawano Y, Narahara H, Matsui N, Miyakawa I. (1998) Premature ovarian failure associated with a Robertsonian translocation. Acta Obstet Gynecol Scand 77:467–469.[Web of Science][Medline]

Knight SJ, Regan R, Nicod A, Horsley SW, Kearney L, Homfray T, Winter RM, Bolton P, Flint J. (1999) Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet 354:1676–1681.[CrossRef][Web of Science][Medline]

Krauss C, Turksoy RN, Atkins L, McLaughlin C, Brown LG, Page DC. (1987) Familial premature ovarian failure due to an interstitial deletion of the long arm of the X chromosome. N Engl J Med 317:125–131.[Abstract]

Maraschio P, Tupler R, Barbierato L, Dainotti E, Larizza D, Bernardi F, Hoeller H, Garau A, Tiepolo L. (1996) An analysis of Xq deletions. Hum Genet 97:375–381.[Web of Science][Medline]

Marozzi A, Manfredini E, Tibiletti MG, Furlan D, Villa N, Vegetti W, Crosignani PG, Ginelli E, Meneveri R, Dalpra L. (2000) Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum Genet 107:304–311.[CrossRef][Web of Science][Medline]

Mumm S, Herrera L, Waeltz PW, Scardovi A, Nagaraja R, Esposito T, Schlessinger D, Rocchi M, Forabosco A. (2001) X/autosomal translocations in the Xq critical region associated with premature ovarian failure fall within and outside genes. Genomics 76:30–36.[CrossRef][Web of Science][Medline]

Orczyk GP, Pehrson J, Leventhal JM. (1989) Premature ovarian failure in a 35 year old woman with a Robertsonian translocation. Int J Fertil 34:184–187.[Web of Science][Medline]

Powell CM, Taggart RT, Drumheller TC, Wangsa D, Qian C, Nelson LM, White BJ. (1994) Molecular and cytogenetic studies of an X; autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet 52:19–26.[CrossRef][Web of Science][Medline]

Prueitt R, Ross JL, Zinn AR. (2000) Physical mapping of nine Xq translocation breakpoints and identification of XPNPEP2 as a premature ovarian failure candidate gene. Cytogenet Cell Genet 89:44–50.[CrossRef][Web of Science][Medline]

Prueitt RL, Chen H, Barnes RI, Zinn AR. (2002) Most X; autosome translocations associated with premature ovarian failure do not interrupt X-linked genes. Cytogenet Genome Res 97:32–38.[CrossRef][Web of Science][Medline]

Rizzolio F, Bione S, Sala C, Goegan M, Gentile M, Gregato G, Rossi E, Pramparo T, Zuffardi O, Toniolo D. (in press) Chromosomal rearrangements in Xq and premature ovarian failure: mapping of 25 new cases and review of the literature. Hum Reprod Epub ahead of print February 23, 2006.

Rossetti F, Rizzolio F, Pramparo T, Sala C, Bione S, Bernardi F, Goegan M, Zuffardi O, Toniolo D. (2004) A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28. Eur J Hum Genet 12:829–834.[CrossRef][Web of Science][Medline]

Sala C, Arrigo G, Torri G, Martinazzi F, Riva P, Larizza L, Philippe C, Jonveaux P, Sloan F, Labella T, Toniolo D. (1997) Eleven X chromosome breakpoints associated with premature ovarian failure (POF) map to a 15-Mb Yac contig spanning Xq21. Genomics 40:123–131.[CrossRef][Web of Science][Medline]

Schlessinger D, Herrera L, Crisponi L, Mumm S, Percesepe A, Pellegrini M, Pilia G, Forabosco A. (2002) Genes and translocations involved in POF. Am J Med Genet 111:328–333.[CrossRef][Web of Science][Medline]

Scriven P, Flinter FA, Braude PR, Ogilvie CM. (2001) Robertsonian translocations-reproductive risks and indications for preimplantation genetic diagnosis. Hum Reprod 16:2267–2273.[Abstract/Free Full Text]

Simpson JL and Rajkovic A. (1999) Ovarian differentiation and gonadal failure. Am J Med Genet 89:186–200.[CrossRef][Web of Science][Medline]

Tharapel A, Anderson KP, Simpson JL, Martens PR, Wilroy RS Jr, Llerena JC Jr, Schwartz CE. (1993) Deletion (X)(q26.1>q28) in a proband and her mother: molecular characterization and phenotypic-karyotypic deductions. Am J Hum Genet 52:19–26.

Therman E, Laxova R, Susman B. (1990) The critical region on the human Xq. Hum Genet 85:455–461.[Web of Science][Medline]

Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P, Van Steirteghem A, Liebaers I. (1996) Cytogenetics of infertile men. Hum Reprod 11:1–24.[Free Full Text]

van Asselt K, Kok HS, Putter H, Wijmenga C, Peeters PH, van der Schouw YT, Grobbee DE, te Velde ER, Mosselman S, Pearson PL. (2004) Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative trait loci influencing variation in human menopausal age. Am J Hum Genet 74:444–453.[CrossRef][Web of Science][Medline]

Vegetti W, Marozzi A, Manfredini E, Testa G, Alagna F, Nicolosi A, Caliari I, Taborelli M, Tibiletti MG, Dalpra L, Crosignani PG. (2000) Premature ovarian failure. Mol Cell Endocrinol 161:53–57.[CrossRef][Web of Science][Medline]

Villanueva A and Rebar RW. (1983) Triple X syndrome and premature ovarian failure. Obstet Gynecol 62:70–73.

Wu R, Kuo PL, Lin SJ, Liu CH, Tzeng CC. (1993) X chromosome mosaicism in patients with recurrent abortion or premature ovarian failure. J Formos Med Assoc 92:953–956.[Medline]

Submitted on January 12, 2006; resubmitted on March 1, 2006; resubmitted on April 4, 2006; accepted on April 13, 2006.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
S. H. Yoon, Y. M. Choi, M. A. Hong, B. M. Kang, J. J. Kim, E. G. Min, J. G. Kim, and S. Y. Moon
X chromosome inactivation patterns in patients with idiopathic premature ovarian failure
Hum. Reprod., March 1, 2008; 23(3): 688 - 692.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B. Mandon-Pepin, P. Touraine, F. Kuttenn, C. Derbois, A. Rouxel, F. Matsuda, A. Nicolas, C. Cotinot, and M. Fellous
Genetic investigation of four meiotic genes in women with premature ovarian failure
Eur. J. Endocrinol., January 1, 2008; 158(1): 107 - 115.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. Tachdjian, A. Aboura, M.-F. Portnoi, M. Pasquier, N. Bourcigaux, T. Simon, G. Rousseau, L. Finkel, M. Benkhalifa, and S. Christin-Maitre
Cryptic Xp duplication including the SHOX gene in a woman with 46,X, del(X)(q21.31) and premature ovarian failure
Hum. Reprod., January 1, 2008; 23(1): 222 - 226.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/9/2329    most recent
del174v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Portnoï, M.F.
Right arrow Articles by Christin-Maitre, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Portnoï, M.F.
Right arrow Articles by Christin-Maitre, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?